Related Articles
People with COPD had more carbon in their lungs than smokers in study
Researchers looked at lung tissue from 28 COPD patients and 15 smokers who underwent surgery for suspected or confirmed lung cancer.
Camlipixant in Refractory Chronic Cough: A Phase 2a, Randomized Controlled Trial (RELIEF)
“.” American Journal of Respiratory and Critical Care Medicine, 211(6), pp. 1072–1075 Correspondence and requests for reprints should be addressed to Jaclyn A. Smith, M.B.…
Adjustable Septal Buttons for the Management of Benign Acquired Tracheoesophageal Fistulas (with Video)
“.” Annals of the American Thoracic Society, 22(6), pp. 934–937 Correspondence and requests for reprints should be addressed to Alma V. Burbano, M.D., Department of…
Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE)
Rationale: There is no broadly accessible treatment for patients with refractory chronic cough, a disease characterized by chronic cough that persists despite treatment for other…
Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR)
Rationale: It is unclear whether carriers of pathogenic variants in PAH-associated genes have a distinct response to PAH treatment. Objectives: To evaluate the effect of…
Why Women Appear to Have Better Outcomes When Undergoing Screening for Lung Cancer
Rationale: Randomized controlled trials (RCTs) of lung cancer (LC) screening (LCS) using computed tomography (CT) documented LC mortality reductions between 7.2% and 29.2%, compared with…
Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR)
Rationale: It is unclear whether carriers of pathogenic variants in PAH-associated genes have a distinct response to PAH treatment. Objectives: To evaluate the effect of…
Final Clinical Year in Review Session Highlights Advances in COPD, Pulmonary Vascular Disease, Pulmonary Rehabilitation, and Lung Cancer – ATSConferenceNews.org
The Clinical Year in Review series at the ATS 2025 International Conference concluded on Wednesday, May 21, with a discussion of impactful studies spanning pulmonary…
Do Differences in Comorbidity Explain Sex-based Differences in Lung Cancer Screening Outcomes?
“.” Annals of the American Thoracic Society, 22(6), pp. 824–825 Artificial Intelligence Disclaimer: No artificial intelligence tools were used in writing this manuscript.
Simplifying Sotatercept in Pulmonary Arterial Hypertension: Genetic Context Meets Treatment Response
“.” American Journal of Respiratory and Critical Care Medicine, 211(6), pp. 906–907 Artificial Intelligence Disclaimer: No artificial intelligence tools were used in writing this manuscript.…